Barcelona clinic liver

Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] B). However, it often leads to a poor prognosis and decreased hepatic function especially in patients with BCLC substage B2.

9p vikolindagrabar 27-07-2022 3 1   Download

The number of young patients with hepatocellular carcinoma (HCC) is increasing, but whether patients of different ages have a survival advantage is unclear. This study was conducted to investigate whether age differences in the Barcelona Clinic Liver Cancer (BCLC) classification system contribute to the long-term survival outcomes of patients with HCC.

9p viangelamerkel 27-07-2022 9 3   Download

In clinical practice, many hepatocellular carcinoma (HCC) patients in Barcelona Clinical Liver Cancer (BCLC) stage A4–B1 cannot receive the curative treatments of liver transplantation, resection, and radiofrequency ablation (RFA), which are the recommended options according to liver cancer guidelines.

12p vimahuateng 26-11-2021 12 1   Download

Patients diagnosed with Barcelona Clinic Liver Cancer (BCLC) intermediate stage hepatocellular carcinoma (HCC) encompass a broad clinical population. Kinki criteria subclassifications have been proposed to better predict prognoses and determine appropriate treatment strategies for these patients.

11p vimahuateng 26-11-2021 7 0   Download

Several staging systems have been developed to evaluate patients with hepatocellular carcinoma (HCC), including the China Staging System (CS), the American Joint Committee on Cancer (AJCC) tumor-node-metastasis (TNM) staging system, and seventh edition; the Barcelona Clinic Liver Cancer (BCLC) staging system, and Cancer of the Liver Italian Program (CLIP) staging system.

9p vinaypyidaw2711 26-08-2020 10 3   Download

Microvascular invasion (MVI) is recognized as a prognostic factor associated with poor outcome in hepatocellular carcinoma (HCC) patients after curative resection. It remains unclear, however, whether MVI can provide prognostic information for patients at a specific tumor stage.

8p vimale2711 21-08-2020 8 1   Download

Microvascular invasion (MVI) is well established as a negative prognostic factor for hepatocelluar carcinoma (HCC). However, its prognostic value in different subgroups of Barcelona Clinical Liver Cancer (BCLC) stages remains to be elucidated.

10p vibaku2711 22-07-2020 8 2   Download

The nomogram of the Barcelona Clinic Liver Cancer (BCLC) for hepatocellular carcinoma (HCC) has been used for outcome prediction. Patients with BCLC stage C HCC often undergo anti-cancer therapy against current treatment guidelines in real world practice.

9p vibaku2711 22-07-2020 9 2   Download

To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular carcinoma (HCC) patients, and to explore the range of tumor sizes suitable for combination therapy.

10p vikuala271 13-06-2020 12 2   Download

Việt Nam vấn đề ung thư gan nguyên phát, hướng dẫn điều trị theo barcelona clinic liver cancer, nguyên lý của RFA, nguyên tắc chung của RFA, các loại thiết bị RFA, kỹ thuật (RFA u gan dưới hướng dẫn siêu âm b-mode, RFA dưới hướng dẫn siêu âm), một số biến đổi kĩ thuật trong RFA u gan nguyên phát (no touch technique, kiểm tra lại bằng clvt, RFA – một số hạn chế) là những nội dung tài liệu trình bày.

39p hanhhanh96 13-11-2018 52 2   Download